Treating Female Infertility and Improving IVF Pregnancy Rates With a Manual Physical Therapy Technique*
Belinda F. Wurn, PT; Lawrence J. Wurn, LMT; C. Richard King, MD; Marvin A. Heuer, MD; Amanda S. Roscow, MPT; Eugenia S. Scharf, PhD; Jonathan J. Shuster, PhD
Context: Infertility and pregnancy
Objective: To assess the effectiveness of site-specific manual soft tissue therapy in (1) facilitating natural fertility and (2) improving in vitro fertilization (IVF) pregnancy rates in women with histories indicating abdominopelvic adhesion formation.
Design and Intervention: Pursuant to 2 promising pilot studies, 53 infertile, premenopausal patients received a 10- to 20-hour series of site-specific manual physical therapy treatments.
Seventeen patients hoped to achieve a natural pregnancy; 36 planned to undergo IVF within 15 months. The primary criteria for inclusion in the studies were the inability to conceive following a minimum of 12 months of unprotected intercourse and suspected or confirmed pelvic adhesions due to abdominal and/or pelvic surgery, infectious or inflammatory disease (eg, endometriosis, PID), or trauma.
Treatments were specifically designed to address biomechanical dysfunctions of the pelvis, sacrum, and coccyx and restricted soft tissue and visceral mobility due to adhesions or microadhesions affecting the reproductive organs and adjacent structures.
Main Outcome Measures: (1) Natural fertility group: pregnancy within 1 year of therapy and subsequent full-term delivery; (2) Pre-IVF group: pregnancy (via transfer of fresh embryos from nondonor eggs) within 15 months of the last manual treatment date.
Results: Natural fertility group: Of the 14 patients available for follow-up (ages 25 to 44; mean, 33.5 years), 10 (71.4%) became pregnant within 1 year, and 9 (64.3%) reported full-term deliveries.
Three of the 9 women who delivered reported a subsequent pregnancy, suggesting that the treatment protocol might have lasting effects. Two women have had a second live birth delivery; and the third is still pregnant.
Pre-IVF group: Of the 25 patients available for follow-up (ages 28 to 44; mean, 36 years), clinical pregnancies were documented in 22 of 33 embryo transfers vs the US Centers for Disease Control and Prevention (CDC) 2001 age-adjusted expected number of 12.7 (P < .001).
The estimated odds ratio for a successful pregnancy in a cycle (manual treatment: no treatment) is 3.20 (95% confidence interval = 1.55–8.4).
Conclusions: The data trend across these studies suggests that this innovative site-specific protocol of manual soft-tissue therapy facilitates fertility in women with a wide array of adhesion-related infertility and biomechanical reproductive organ dysfunction.
The therapy, designed to improve function by restoring visceral, osseous, and soft-tissue mobility, is a nonsurgical, noninvasive manual technique with no risks and few, if any, adverse side effects or complications.
As such, it should be considered a new adjunct to existing medical infertility treatments.
*Wurn Technique®, patent pending
Medscape General Medicine 6(2), 2004. 6/04
Belinda F. Wurn, PT, Clear Passage Therapies, Gainesville, Florida; Lawrence J. Wurn, LMT, Clear Passage Therapies, Gainesville, Florida; C. Richard King, MD, Florida Medical and Research Institute, P.A., Gainesville, Florida; Marvin A. Heuer, MD, College of Medicine, University of Florida, Gainesville, and Iovate Health Sciences Services, Inc. Toronto, Ontario; Amanda S. Roscow, MPT, Clear Passage Therapies, Gainesville, Florida; Eugenia S. Scharf, PhD, medical writer/researcher, Gainesville, Florida; Jonathan J. Shuster, PhD, Dept. of Statistics, College of Medicine, University of Florida, Gainesville
Disclosure: Belinda F. Wurn, PT and Lawrence J. Wurn, LMT, are the sole shareholders of Clear Passage Therapies, Inc. The entirety of the shares of the corporation are equally divided, 50% to each. Wurn Technique is a Therapeutic Method for Treating Infertility in Humans and Animals, patent pending with the United States Patent and Trademark Office, Application No. 09/887,884 filed June 22, 2001 by Lawrence J. Wurn and Belinda F. Wurn.
Disclosure: Amanda S. Roscow, MPT, is an employee of Clear Passage Therapies, Inc., Gainesville, Florida.
Disclosure: Marvin A. Heuer, MD has no significant financial interests or relationships to disclose.
Disclosure: C. Richard King, MD has no significant financial interests or relationships to disclose.
Disclosure: Eugenia S. Scharf, PhD has no significant financial interests or relationships to disclose.
Disclosure: Jonathan J. Shuster, PhD has no significant financial interests or relationships to disclose.
Disclosure: Belinda F. Wurn, PT, "had full access to all the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis."
Corresponding Author: L.J. Wurn, Clear Passage Therapies, 3600 NW 43rd Street, Suite A-1, Gainesville FL 32606. www.clearpassage.com E-mail: email@example.com
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.